IMOVAX RABIES 2.5 UNIT
INACTIVATED RABIES VIRUS (PM/WI38 1503-3M) : 2.5 UNIT · DIN 01908286 · SANOFI PASTEUR LIMITED
Health Canada status: MARKETED
What is IMOVAX RABIES?
IMOVAX RABIES 2.5 UNIT contains INACTIVATED RABIES VIRUS (PM/WI38 1503-3M) : 2.5 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01908286, held by SANOFI PASTEUR LIMITED, supplied as POWDER FOR SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 12-Apr-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is IMOVAX RABIES used for?
IMOVAX® Rabies is indicated for the active immunization of individuals of all age groups to prevent disease caused by the rabies virus. It is indicated for both pre-exposure prophylaxis and post-exposure prophylaxis. IMOVAX® Rabies should be used in accordance with official recommendations.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01908286 |
|---|---|
| Brand name | IMOVAX RABIES |
| Generic / active ingredient | INACTIVATED RABIES VIRUS (PM/WI38 1503-3M) : 2.5 UNIT |
| Manufacturer | SANOFI PASTEUR LIMITED |
| Strength | 2.5 UNIT |
| Dosage form | POWDER FOR SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07BG01 RABIES, INACTIVATED, WHOLE VIRUS |
| AHFS class | 80:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Apr-2006 |
| Original market date | 1999-08-13 00:00:00 |
How is it stored and handled?
null
How is it supplied?
single dose vials of lyophilized vaccine with 1 mL of diluent (sterile water for injection) contained in a disposable (Luer™-lok) syringe with two needles (1 x 25G x 16 mm and 1 x 25G x 25 mm); single dose vials of lyophilized vaccine with 1 mL of diluent (sterile water for injection) contained in a disposable syringe with two needles (1 x 25G x 16 mm and 1 x 25G x 25 mm); single dose vials of lyophilized vaccine with 1 mL of diluent (sterile water for injection) contained in a disposable syringe with an attached needle. Not all presentations and pack sizes may be marketed.
What can be used instead?
Other Canadian products sharing ATC code J07BG01 RABIES, INACTIVATED, WHOLE VIRUS. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| RABAVERT | 2.5 UNIT | POWDER FOR SOLUTION | BAVARIAN NORDIC AS | MARKETED | DIN 02267667 |
| RABIES VACCINE INACTIVATED DRIED | 2.5 UNIT | POWDER FOR SOLUTION | AVENTIS PASTEUR LIMITED | CANCELLED POST MARKET | DIN 00639621 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.